RhumbLine Advisers’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,260
Closed -$14K 3318
2022
Q1
$14K Sell
1,260
-205
-14% -$2.61K ﹤0.01% 3006
2021
Q4
$23K Buy
1,465
+1
+0.1% +$21 ﹤0.01% 2998
2021
Q3
$35K Buy
1,464
+93
+7% +$2.8K ﹤0.01% 3029
2021
Q2
$48K Sell
1,371
-9
-0.7% -$358 ﹤0.01% 2976
2021
Q1
$66K Buy
1,380
+30
+2% +$1.74K ﹤0.01% 2967
2020
Q4
$65K Buy
1,350
+139
+11% +$5.23K ﹤0.01% 3009
2020
Q3
$43K Sell
1,211
-314
-21% -$17.7K ﹤0.01% 2958
2020
Q2
$105K Buy
+1,525
New +$60.8K ﹤0.01% 2958
2019
Q2
Sell
-1,817
Closed -$25K 3029
2019
Q1
$25K Sell
1,817
-8
-0.4% -$93 ﹤0.01% 2932
2018
Q4
$15K Buy
1,825
+549
+43% +$9.62K ﹤0.01% 2972
2018
Q3
$30K Sell
1,276
-28
-2% -$1.06K ﹤0.01% 2915
2018
Q2
$65K Buy
1,304
+310
+31% +$15.3K ﹤0.01% 2898
2018
Q1
$45K Sell
994
-65
-6% -$3.26K ﹤0.01% 2798
2017
Q4
$48K Sell
1,059
-6
-0.6% -$318 ﹤0.01% 2817
2017
Q3
$66K Sell
1,065
-39
-4% -$2.28K ﹤0.01% 2889
2017
Q2
$70K Buy
+1,104
New +$61.2K ﹤0.01% 2914

Other funds holding NH

RhumbLine Advisers's NH Position: Q2 2022 in Review

RhumbLine Advisers sold out of NantHealth, Inc (NH) in Q2 2022, closing a stake of 1,260 shares — an estimated $14K sold.

RhumbLine Advisers first reported a position in NH in Q2 2017 and held it in 16 quarters. The position peaked at $105K in Q2 2020. 42 funds tracked by Wall St. Rank hold NH as of Q2 2022.

  • RhumbLine Advisers reported no remaining NantHealth, Inc position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 1,260 NantHealth, Inc shares in Q2 2022, an estimated $14K.
  • RhumbLine Advisers first reported a position in NantHealth, Inc in Q2 2017 and held it in 16 quarters.
  • RhumbLine Advisers's NantHealth, Inc position peaked at $105K in Q2 2020.
  • 42 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.